1-13 of 13
Christopher Graham
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Allogeneic hematopoietic stem cell transplantation for hematological malignancies using nonmyeloablative fludarabine, cyclophosphamide, 200 centigray total body irradiation, and post-transplant cyclophosphamide, sirolimus, and mycophenolate mofetil for graft-versus-host disease prophylaxis is associated with low non-relapse mortality.

Free
Christopher Graham, Roy Kao, Qing Cao, Punita Grover, Joseph Norton, Cameron McDonald-Hyman, Joseph Maakaron, Jeremy Allred, Veronika Bachanova, Jeffrey Miller, Daniel Weisdorf, Mark Juckett
Journal: Blood
Blood (2025) 146 (Supplement 1): 4220.
https://doi.org/10.1182/blood-2025-4220
Published: 2025
Journal Articles

Coronary artery calcification and its effect on cardiac events in patients undergoing allogeneic stem cell transplantation using nonmyeloablative conditioning

Free
Christopher Graham, Roy Kao, Qing Cao, Cameron McDonald-Hyman, Joseph Norton, Punita Grover, Joseph Maakaron, Jeremy Allred, Veronika Bachanova, Jeffrey Miller, Daniel Weisdorf, Mark Juckett
Journal: Blood
Blood (2025) 146 (Supplement 1): 4219.
https://doi.org/10.1182/blood-2025-4219
Published: 2025
Journal Articles

Risk of relapse and mortality after non-myeloablative allogeneic stem cell transplant for Acute Myeloid Leukemia and myelodysplastic syndrome after fludarabine, cyclophosphamide, and 200 centigray total body irradiation  with gvhd prophylaxis using post-transplant cyclophosphamide, sirolimus, and mycophenolate mofetil: Impact of maintenance chemotherapy

Free
Christopher Graham, Roy Kao, Qing Cao, Cameron McDonald-Hyman, Joseph Norton, Punita Grover, Joseph Maakaron, Jeremy Allred, Veronika Bachanova, Jeffrey Miller, Daniel Weisdorf, Mark Juckett
Journal: Blood
Blood (2025) 146 (Supplement 1): 7781.
https://doi.org/10.1182/blood-2025-7781
Published: 2025
Journal Articles

A post-marketing pharmacovigilance analysis of cardiotoxicities following chimeric antigen receptor T-cell therapy using the FDA adverse event reporting system

Free
Malvika Gupta, Supriya Gupta, Christopher Graham
Journal: Blood
Blood (2025) 146 (Supplement 1): 6301.
https://doi.org/10.1182/blood-2025-6301
Published: 2025
Journal Articles

Gtb-3650 (anti-CD16/IL-15/anti-CD33) tri-specific killer engager (TriKE®) for the treatment of high risk myelodysplastic syndromes (MDS) and refractory/relapsed (R/R) Acute Myeloid Leukemia (AML) (NCT06594445)

Free
Mark Juckett, Christopher Graham, Punita Grover, Joseph Norton, Naveen Premnath, Craig Eckfeldt, Zohar Sachs, Cassie Seichter, Andrea Hoeschen, Cameron McDonald-Hyman, Jeremy Allred, Rose Wangen, Martin Felices, Jeffrey Miller
Journal: Blood
Blood (2025) 146 (Supplement 1): 6947.
https://doi.org/10.1182/blood-2025-6947
Published: 2025
Journal Articles

The Impact of Induction Regimens on Clinical Outcomes in Double and Triple-Hit Lymphoma: A Meta-Analysis of Comparative Studies

Free
Philip A Haddad, Frankie Powell, Jr., Ankita Gupta, Christopher Graham
Journal: Blood
Blood (2023) 142 (Supplement 1): 4500.
https://doi.org/10.1182/blood-2023-174369
Published: 2023
Journal Articles

Fluid-Overload Associated Large B-Cell Lymphoma Clinicopathologic Features and Determinants of Outcomes: Analysis of a Pooled Database

Free
Christopher Graham, Supriya Gupta, Philip A Haddad
Journal: Blood
Blood (2023) 142 (Supplement 1): 6320.
https://doi.org/10.1182/blood-2023-174337
Published: 2023
Journal Articles

Double/Triple Hit Lymphoma Descriptors and Clinicopathologic Determinants of Survival: Analysis of a Pooled Database

Free
Philip A Haddad, Supriya Gupta, Ankita Gupta, Christopher Graham
Journal: Blood
Blood (2023) 142 (Supplement 1): 6298.
https://doi.org/10.1182/blood-2023-182479
Published: 2023
Journal Articles

Primary Effusion Lymphoma (PEL) and Primary Effusion-like Lymphoma (PEL-LL): A Comparative Study of Clinicopathologic Features and Outcomes

Free
Supriya Gupta, Christopher Graham, Philip A Haddad
Journal: Blood
Blood (2023) 142 (Supplement 1): 4477.
https://doi.org/10.1182/blood-2023-174336
Published: 2023
Journal Articles

Splenic Diffuse Red Pulp Small B-Cell Lymphoma Descriptors and Clinicopathologic Determinants of Clinical Outcomes: Analysis of a Pooled Database

Free
Supriya Gupta, Christopher Graham, Philip A Haddad
Journal: Blood
Blood (2022) 140 (Supplement 1): 3632.
https://doi.org/10.1182/blood-2022-168197
Published: 2022
Journal Articles

Complex Restrictive Lung Disease Patterns Affecting Survival and Outcomes in Patients Undergoing Allogeneic Stem Cell Transplant: A Single-Institution Retrospective Analysis

Free
Christopher Graham, Runhua Shi, Gerhard C. Hildebrandt
Journal: Blood
Blood (2022) 140 (Supplement 1): 7674–7675.
https://doi.org/10.1182/blood-2022-167904
Published: 2022
Journal Articles

Risk of Intracranial Hemorrhage with Direct Oral Anticoagulants (DOACs) Versus Low Molecular Weight Heparin (LMWH) in Primary and Secondary Brain Cancers: An up-to-Date Meta-Analysis of Comparative Studies

Free
Philip A Haddad, Christopher Graham, Dalia Hammoud
Journal: Blood
Blood (2022) 140 (Supplement 1): 5677.
https://doi.org/10.1182/blood-2022-157409
Published: 2022
Journal Articles

Survival Determinants in Primary Intestinal NK/T-Cell Lymphoma (PINKTCL): Analysis of a Pooled Database

Free
Philip A Haddad, Christopher Graham
Journal: Blood
Blood (2021) 138 (Supplement 1): 1396.
https://doi.org/10.1182/blood-2021-145014
Published: 2021